Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Kamiya

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
Journal of the American Medical Directors Association|November 14, 2024
Prognostic Value of Sarcopenia Definitions and Outcomes Consortium Criteria in Older Patients with Heart FailureTaisuke Nakade, Daichi Maeda, Yuya Matsue, et al.
The Canadian Journal of Cardiology|August 22, 2024
Prognostic Impact of Sarcopenia Assessed Using Modified Asian Working Group for Sarcopenia 2019 Criteria in Heart FailureTaisuke Nakade, Daichi Maeda, Yuya Matsue, et al.
European Journal of Heart Failure|June 6, 2020
Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort studyYuya Matsue, Kentaro Kamiya, Hiroshi Saito, et al.
European Journal of Preventive Cardiology|October 4, 2025
Prognostic utility of the Global Leadership Initiative on Sarcopenia model in older patients with heart failure: post-hoc analysis of the FRAGILE-HF studyTaisuke Nakade, Daichi Maeda, Yuya Matsue, et al.
European Journal of Preventive Cardiology|February 24, 2021
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fractionMasaaki Konishi, Nobuyuki Kagiyama, Kentaro Kamiya, et al.
Journal of the American Heart Association|May 10, 2024
Prognostic Value of Objective Social Isolation and Loneliness in Older Patients With Heart Failure: Subanalysis of FRAGILE-HF and Kitasato CohortHiroshi Saito, Daichi Maeda, Nobuyuki Kagiyama, et al.
JACC. Advances|July 15, 2026
Age-Stratified Prognostic Value of Cardiopulmonary Exercise Testing Parameters in Patients With Heart FailureKen Ogura, Kentaro Kamiya, Nobuaki Hamazaki, et al.
Journal of the American Heart Association|September 2, 2021
Impact of Social Frailty in Hospitalized Elderly Patients With Heart Failure: A FRAGILE-HF Registry SubanalysisKentaro Jujo, Nobuyuki Kagiyama, Kazuya Saito, et al.
The American Journal of Cardiology|January 22, 2022
Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology/American Heart Association Blood Pressure GuidelineYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
American Journal of Nephrology|March 8, 2022
Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based DatabaseYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
Journal of the American Medical Directors Association|November 14, 2024
Prognostic Value of Sarcopenia Definitions and Outcomes Consortium Criteria in Older Patients with Heart FailureTaisuke Nakade, Daichi Maeda, Yuya Matsue, et al.
The Canadian Journal of Cardiology|August 22, 2024
Prognostic Impact of Sarcopenia Assessed Using Modified Asian Working Group for Sarcopenia 2019 Criteria in Heart FailureTaisuke Nakade, Daichi Maeda, Yuya Matsue, et al.
European Journal of Heart Failure|June 6, 2020
Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort studyYuya Matsue, Kentaro Kamiya, Hiroshi Saito, et al.
European Journal of Preventive Cardiology|October 4, 2025
Prognostic utility of the Global Leadership Initiative on Sarcopenia model in older patients with heart failure: post-hoc analysis of the FRAGILE-HF studyTaisuke Nakade, Daichi Maeda, Yuya Matsue, et al.
European Journal of Preventive Cardiology|February 24, 2021
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fractionMasaaki Konishi, Nobuyuki Kagiyama, Kentaro Kamiya, et al.
Journal of the American Heart Association|May 10, 2024
Prognostic Value of Objective Social Isolation and Loneliness in Older Patients With Heart Failure: Subanalysis of FRAGILE-HF and Kitasato CohortHiroshi Saito, Daichi Maeda, Nobuyuki Kagiyama, et al.
JACC. Advances|July 15, 2026
Age-Stratified Prognostic Value of Cardiopulmonary Exercise Testing Parameters in Patients With Heart FailureKen Ogura, Kentaro Kamiya, Nobuaki Hamazaki, et al.
Journal of the American Heart Association|September 2, 2021
Impact of Social Frailty in Hospitalized Elderly Patients With Heart Failure: A FRAGILE-HF Registry SubanalysisKentaro Jujo, Nobuyuki Kagiyama, Kazuya Saito, et al.
The American Journal of Cardiology|January 22, 2022
Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology/American Heart Association Blood Pressure GuidelineYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
American Journal of Nephrology|March 8, 2022
Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based DatabaseYuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
Pageof 27